Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat

British Journal of Pharmacology

Volumn 119, Issue 1, 1996, Pages 107-114

  Stein, Elliot A ^a,b   Fuller, Scott A ^a   Edgemond, William S ^a   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Department of Psychiatry ^*  (United States)

Author keywords

Anandamide; Blood pressure; Endogenous cannabinoid; Heart rate; Temperature

Indexed keywords

ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BRADYCARDIA; BRAIN; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPERREFLEXIA; HYPOTHERMIA; LOCOMOTION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

EID: 0029812415     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15683.x     Document Type: Article

References (34)

1. ADAMS, M.D., EARNHARDT, J.T., DEWEY, W.L. & HARRIS, L.S. (1976). Vasoconstrictor actions of Δ8 and Δ9-tetrahydrocannabinol in the rat. J. Pharmacol. Exp. Ther., 196, 649-656.
2. AGURELL, S., HALLDIN, M., LINDGREN, J., OHLSSON, A., WIDMAN, M., GILLESPIE, H. & HOLLISTER, L. (1986). Pharmacokinetics and metabolism of A'tetrahydrocannabinoids with emphasis on man. Pharmacol. Rev., 38, 21-43.
3. 9-tetrahydrocannabinol in the rat and mouse. Psychopharmacologia, 25, 275 - 280.
4. CHILDERS, S.R., SEXTON, T. & ROY, M.B. (1994). Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol., 47, 711 - 715.
5. CRAWLEY, J.N., CORWIN, R.L., ROBINSON, J.K., FELDER, C.C., DEVANE, W.A. & AXELROD, J. (1993). Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol. Biochem. Behav., 46, 967-972.
6. DEUTSCH, D.G. & CHIN, S.A. (1993). Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol., 46, 791-796.
7. DEVANE, W.A., DYSARZ, F.A. III., JOHNSON, M.R., MELVIN, L.S. & HOWLETT, A.C. (1988). Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol., 34, 605-613.
8. DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
9. DEWEY, W.L. (1986). Cannabinoid pharmacology. Pharmacol. Rev. 38, 151-178.
10. EVANS, D.M., JOHNSON, M.R. & HOWLETT, A.C. (1992). Calcium-dependent release from rat brain of a cannabinoid binding activity. J. Neurochem., 58, 780-782.
11. FELDER, C.C., BRILEY, E.M., AXELROD, J., SIMPSON, J.T., MACKIE, K. & DEVANE, W.A. (1993). Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A., 90, 7656-7660.
12. FERRI, S., COSTA, G., MURARI, G., PANICO, A.M., RAPISAARDA, E., SPERONI, E. & ARRIGO-REINA, R. (1981). Investigations on behavioral effects of an extract of Cannibis sativa L in the rat. Psychopharmacology, 75, 144.
13. FRIDE, E. & MECHOULAM, R. (1993). Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol., 231, 313-314.
14. HERKENHAM, M., GROEN, B.G.S., LYNN, A.B., DECOSTA, B.R. & RICHFIELD, E.K. (1991a). Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Res., 552, 301-310.
15. HERKENHAM, M., LYNN, A.B., JOHNSON, M.R., MELVIN, L.S., DECOSTA, B.R. & RICE, K.C. (1991b). Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 11, 563-583.
16. HERKENHAM, M., LYNN, A.B., LITTLE, M.D., JOHNSON, M.R., MELVIN, L.S., DECOSTA, B.R. & RICE, K.C. (1990). Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A., 87, 1932-1936.
17. HILLARD, C.J., EDGEMOND, W.S. & CAMPBELL, W.B. (1995). Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. J. Neurochem., 64, 677-683.
18. HOWLETT, A.C., BIDAUT-RUSSELL, M., DEVANE, W.A., MELVIN, L.S., JOHNSON, M.R. & HERKENHAM, M. (1990). The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci., 13, 420-423.
19. IRWIN, S., HAUDE, R.W., BENNERR, D.R., HENDERSHOT, L.C. & SEEVERS, M.H. (1951). The effects of morphine, methadone and meperidine on some reflexive responses of spinal animals to nociceptive stimulation. J. Pharmacol. Exp. Ther., 101, 132-143.
20. LICHTMAN, A.H. & MARTIN, B.R. (1991). Spiral and supraspiral mechanisms of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther., 258, 517-523.
21. LUKACSKO, P., MESSINA, E.J. & KALEY, G. (1980). Reduced hypotensive action of arachidonic acid in the spontaneously hypertensive rat. Hypertension, 2, 657-663.
22. MACKIE, K. & HILLE, B. (1992). Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci U.S.A., 89, 3825-3829.
23. MAILLEUX, P. & VANDERHAEGHEN, J.J. (1992). Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience, 48, 655-668.
24. MARTIN, B.R. (1985). Structural requirements for cannabinoid-induced antinociceptive activity in mice. Life Sci., 36, 1523-1530.
25. MATSUDA, L.A., BONNER, T.I., LOLAIT, S.J. (1993). Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol., 327, 535-550.
26. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor: functional expression of the cloned cDNA. Nature, 346, 561-563.
27. O'CALLAGHAN, J.P. & HOLTZMAN, S.G. (1975). Quantification of the analgesic activity of narcotic antagonists by a modified hot plate procedure. J. Pharmacol. Exp. Ther., 192, 497-505.
28. PERTWEE, R.G. (1985). Effects of cannabinoids on thermoregulation: a brief review. In Marijuana '84, ed. Harvey, D.J., pp 263-277. Oxford: IRL Press.
29. SCHMAUSS, C. & YAKSH, T.L. (1984). In vivo studies on spinal opiate receptor systems mediating antinociception II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J. Pharmacol. Exp. Ther., 228, 1-12.
30. SMITH, P.B., COMPTON, D.R., WELCH. S.P., RAZDAN, R.K., MECHOULAM, R. & MARTIN, B.R. (1994). The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther., 270, 219-227.
31. 9-tetrahydrocannabinol on body temperature and brain amines of the rat. Eur. J. Pharmacol., 46, 93-99.
32. TULUNAY, F.C., AYHAN, I.H. & SPARBER, S.B. (1982). The effects of morphine and delta-9 tetrahydrocannabinol on motor activity in the rat. Psychopharmacology, 78, 358-360.
33. VARGA, K., LAKE, K., MARTIN, B.R. & KUNOS, G. (1995). Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol., 278, 279-283.
34. VOGEL, Z., BARG, J., LEVY, R., SAYA, D., HELDMAN, E. & MECHOULAM, R. (1993). Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem., 61, 352-355.